Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 8, August, p. 1081–1084

doi: 10.17219/acem/70809

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Risk factors of the Clostridium difficile infection in patients with chronic kidney disease

Łukasz Lis1,A,B,C,D,E,F, Patryk Jerzak1,A,B,E,F, Andrzej Konieczny1,C,D,E,F, Michał Sroka1,A,B, Barbara Noceń-Rychlewska1,E,F, Paweł Podgórski1,E,F, Wojciech Witkiewicz1,E,F, Zbigniew Hruby1,A,C,D,E,F

1 Research and Development Center, Provincial Specialist Hospital in Wrocław, Poland

Abstract

Background. Clostridium difficile (C. difficile) is a Gram-positive bacillus responsible for diarrhea and colitis, mainly among hospitalized patients. It is a leading cause of nosocomial infections.
Objectives. The main goal of the study was to assess the risk factors of the C. difficile infection in patients with chronic kidney disease (CKD).
Material and Methods. We evaluated the medical records of all patients treated at the Department of Nephrology and Renal Transplantation of the Research and Development Center in the Provincial Specialist Hospital in Wrocław, Poland, between February 2009 and May 2012, who developed diarrhea, abdominal pain and/or fever within 72 h after admission. In patients with these symptoms, an enzyme cassette immunoassay was performed to detect antigens of C. difficile toxins A and B in stool.
Results. There were 207 patients enrolled in the study, presented with the symptoms of the C. difficile infection. Out of these patients, 69 (33%) persons were positive for C. difficile toxins. Longer hospitalization time and lower initial serum albumin concentration significantly increased the risk of infection (p < 0.05). Apart from the C. difficile infection, age, the number of used antibiotics, longer hospitalization time, and lower initial serum albumin concentration significantly augmented the risk of death (p < 0.05).
Conclusion. In patients with CKD, longer hospitalization time and lower serum albumin concentration significantly increased the risk of the C. difficile infection. The C. difficile infection, age, the number of used antibiotics, longer hospitalization time, and lower initial serum albumin concentration notably augmented the risk of death. Although the incidence of the C. difficile infection did not correlate with the estimated glomerular filtration rate (eGFR), 67% of patients who tested positive were class 5 of CKD, whereas only 5.7% were class 1.

Key words

malnutrition, Clostridium difficile, chronic renal insufficiency, pseudomembranous enterocolitis

References (14)

  1. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of clostridium difficile in hospitalized patients: A French multicenter study. Arch Intern Med. 1996;156:1449–1454.
  2. Kyne L, Merry C, O’Connell B, Kelly A, Keane C, O’Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing. 1999;28:107–113.
  3. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–2449.
  4. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1–15.
  5. Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial clostridium difficile infection. Arch Intern Med. 2010;170:784–790.
  6. Keller JM, Surawicz CM. Clostridium difficile infection in the elderly. Clin Geriatr Med. 2014;30:79–93.
  7. Eui Oh S, Lee SM, Lee YK, et al. Clostridium difficile-associated diarrhea in dialysis patients. Kidney Res Clin Pract. 2013;32:27–31.
  8. Kujawa-Szewieczek A, Adamczak M, Kwiecien K, Dudzicz S, Prazak Z, Wiecek A. Analysis of Clostridium difficile infections in patients hospitalized at the nephrological ward in Poland. Postepy Hig Med Dosw (online). 2016;70:505–513.
  9. Lucado J, Gould C, Elixhauser A. Clostridium difficile Infections (CDI) in hospital stays, 2009. HCUP Statistical Brief #124. January, 2012. Agency for Healthcare Research and Quality, Rockville, USA. http://www.hcup-us.ahrq. Accessed February 10, 2017.
  10. Alcala L, Martin A, Marin M, et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem? Clin Microbiol Infect. 2012;18:E204–213.
  11. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: Admission prevalence and risk factors. Am J Infect Control. 2013;41:390–393.
  12. Zarroug N, Lewthwaite P, Beeching N, Beadsworth M. A novel algorithm for the management of clostridum difficile associated diarrhoea. J Infect. 2011;63:e94–e95.
  13. Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton). 2010;15:471–475.
  14. Cunney RJ, Magee C, McNamara E, Smyth EG, Walshe J. Clostridium difficile colitis associated with chronic renal failure. Nephrol Dial Transplant. 1998;13:2842–2846.
© Wroclaw Medical University